Inflammasome formation in the lungs of patients with fatal COVID-19

Toldo, Stefano, Bussani, Rossana, Nuzzi, Vincenzo, Bonaventura, Aldo, Mauro, Adolfo G., Cannatà, Antonio, Pillappa, Raghavendra, Sinagra, Gianfranco +3 more·2021·Inflammation Research
DOI 10.1007/s00011-020-01413-2

Cited by (132)

Items 101–132 of 132

  1. The role of pyroptosis in viral infection
    Zhen Zhao, Yan Zhang, Bing Luo · 2024 · Archives of Virology
  2. A Heparan Sulfate Mimetic RAFT Copolymer Inhibits SARS‐CoV‐2 Infection and Ameliorates Viral‐Induced Inflammation
    Jiaxin Ling, Åke Lundkvist, Marco Guerrini, Vito Ferro, Jin-Ping Li, Jinlin Li · 2024 · Advanced Science
  3. The effect of Borago officinalis on the signaling pathway of the NLRP3 inflammasome complex, TLR4 and some inflammatory cytokines in type II diabetic patients with acute respiratory distress syndrome
    Yanqiu Yue, Fengbin Jin, Xiaohui Yue · 2021 · Cellular and Molecular Biology
  4. Sex differences in coronavirus disease 2019 myocarditis
    Danielle J. Beetler, DeLisa Fairweather · 2023 · Current Opinion in Physiology
  5. The Role of Inflammasomes in COVID-19: Potential Therapeutic Targets
    Chen Sun, Hangyuan Zhao, Yunze Han, Yiqing Wang, Xiao Sun · 2022 · Journal of Interferon & Cytokine Research
  6. Difficult-to-treat recurrent pericarditis after SARS-CoV-2 vaccination
    Michele Marchetta, Rocio I Lopez, Michele Golino, Georgia K. THOMAS, Antonio Abbate · 2025 · International Journal of Cardiology
  7. Response to pegylated interferon in a COVID‐19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus
    Arthur Edward Frankel, Wai C. Yip, Eknath Naik, Hans Carl Hasselbalch · 2021 · Clinical Case Reports
  8. NLRP3 Inflammasome Activation by Oxidative Stress and Its Implications for Vaccination-Related Adverse Events
    Todd D. Terhune, Taravat Ghafourian, Richard C. Deth · 2024 · Preprints.org
  9. Ace2 safeguards embryonic hematopoietic stem and progenitor cell production by restraining Nlrp3-mediated pyroptosis
    Jun Xia, Lingxue Shen, Yining Liu, Lu Wang, Feng Liu · 2025 · Proceedings of the National Academy of Sciences
  10. Identifying Inflammasome Activation in Human Tissues
    Eleonora Mezzaroma, Adolfo Gabriele Mauro, Stefano A Toldo · 2023 · Methods in molecular biology
  11. Evaluation of the relationship between serum interleukin-1β levels and expression of inflammasome-related genes in patients with COVID-19
    Zahra Bagheri‐Hosseinabadi, Ali Shamsizadeh, Fatemeh Bahrehmand, Mitra Abbasifard · 2023 · BMC Immunology
  12. Vascular Inflammation in Lungs of Patients with Fatal Coronavirus Disease 2019 (COVID-19): Possible Role for the NLRP3 Inflammasome
    Oindrila Paul, Jian Qin Tao, Eric West, Leslie A. Litzky, Michael D. Feldman, Kathleen T. Montone, Chamith S. Rajapakse, Christian Andres Bermudez, Shampa Chatterjee · 2021 · Research Square
  13. Putative Therapeutic Impact of Inflammasome Inhibitors against COVID-19-Induced ARDS
    Seyed Fazel Nabavi, Adeleh Sahebnasagh, Ahad Shahbazi, Seyed Mohammad Nabavi, Saeed Azimi, Malihe Khayat Kashani, Solomon Habtemariam, Mojde Rahmani, Mohadese Badiee, Javad Hashemi et al. · 2022 · Current Medicinal Chemistry
  14. An Introduction to the Pathogenetic Mechanisms of CoViD19 Complications
    Umair Mallick · 2022 · Springer eBooks
  15. NLRP3 inflammasome activation and its inhibitory drugs in connection with COVID-19 infection
    Khashayar Zafar-Mohammadi, Javad Poursamimi, Mahdi Atabaki · 2022 · European Journal of Inflammation
  16. LRR protein RNH1 dampens the inflammasome activation and is associated with adverse clinical outcomes in COVID-19 patients
    Giuseppe Bombaci, Mayuresh Anant Sarangdhar, Nicola Daniele Andina, Aubry Tardivel, Eric Chi-Wang Yu, Gillian M. Mackie, Matthew Pugh, Vedat Burak Ozan, Yara Banz, Thibaud Spinetti et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  17. Safety and Efficacy of Disulfiram in Hospitalized Patients with Moderate COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial
    Augusto César de Andrade Mota, Valdir Cerqueira de Sant’Ana Filho, Carolyn M. Hendrickson, Rachel M. DeVay, Matt L. Donne, An M. Nguyen, Caroline Junqueira, Mark T. Marino, Munish Mehra, Ransi M. Somaratne et al. · 2023 · medRxiv
  18. Dynamic Zero-Covid strategy curtails mutagenesis and emergence of new variants of the SARS-CoV-2
    Lunbiao Cui, Liguo Zhu, Jun Zhang, Huafeng Fan, Yongxiang Yi, Jun Fang Zhao, Yiyue Ge, Shenjiao Wang, Xu Han, Xingsu Gao et al. · 2021 · Research Square
  19. Hit Early: Blocking Interleukin-1 in the Treatment of COVID-19 Pneumonia
    Evangelos J. Giamarellos‐Bourboulis, Maria Mouktaroudi, Mihai Gheorghe Netea · 2022 · Annual update in intensive care and emergency medicine
  20. Isquemia arterial bilateral espontánea de extremidades inferiores por COVID-19 leve
    Paulo Francisco Mera-Martínez, Marco Tobar-Marcillo, Aida Gabriela Guerrero-Montero, Julieth Benavides Recalde, Gissel Alejandra Burbano Andrade, José Dario Portillo · 2022 · Revista Repertorio de Medicina y Cirugía
  21. Níveis plasmáticos de HLA-G solúvel em pacientes com covid-19
    Jéssica Fernanda Corrêa Cordeiro · 2022
  22. Ginkgo biloba Extract Containing Plasmalogen May Improve Long COVID and Brain Fog: A Case Report
    Satoshi Kawakami, Yoshimu Tanaka, Tsutomu Satō, Takaharu Ide, Masaaki Usui, Shigehisa Iida, Taro Shirakawa, Yoshitaka Fukuzawa · 2022 · Journal of Biomedical Research & Environmental Sciences
  23. Intravenous high dose vitamin C and ozonated saline effective treatment for Covid -19: The Evolution of Local Standard of Care
    Deborah Viglione, James A. Thorp · 2023 · The Gazette of Medical Sciences
  24. Ativação do inflamassoma: a importância na leishmaniose, na influenza e na COVID-19
    Keyla Santos Guedes de Sá · 2022
  25. Innate immune responses in COVID-19
    Etienne D. Jacotot, Laura Talamini, Srinivasa Reddy Bonam, Angelica Thomas Vieira, Véronique Frémeaux‐Bacchi, Marko Z. Radic, Marie‐Agnès Dragon‐Durey, José Manuel Lozano, Rafael Simone Saia, Sylviane Muller · 2023 · Elsevier eBooks
  26. Potential Mechanism of Colchicine against COVID-19 and Non-Small Cell Lung Cancer based on Network Pharmacology and Bioinformatics Analysis
    Zhiyao Liu, Hailiang Huang, Ying Yu, Yuqi Jia, Lingling Li, Xin Shi, Fangqi Wang · 2022 · Indian Journal of Pharmaceutical Sciences
  27. Importância do inflamassoma no desenvolvimento das formas graves de COVID-19 em pacientes e em modelo experimental murino
    Tamara Silva Rodrigues · 2022
  28. Involvement of NLRP3 Inflammasome in SARS-Cov-2-Induced Multiorgan Dysfunction in Patients with COVID-19: A Review of Molecular Mechanisms.
    Zahra Babazadeh · 2023 · PubMed Central
  29. COVID-19 Induces Greater NLRP3 Inflammasome Activation in Obese Patients than Other Chronic Illnesses: A Case–Control Study
    Raíssa Campos D’Amico, Seigo Nagashima, Lucas Baena Carstens, Karina Bertoldi, Sabrina Mataruco, Júlio César Honório D’Agostini, Elisa Carolina Hlatchuk, Sofia Brunoro da Silva, Lúcia de Noronha, Cristina Pellegrino Baena · 2025 · International Journal of Molecular Sciences
  30. Modulation of immune responses by opioids through toll-like and P2X receptor signaling in COVID-19
    Mohammad Abbas Sheikholeslami, Siavash Parvardeh, Shiva Ghafghazi, Malek Zarei · 2026 · Purinergic Signalling
  31. Adiponectin Signaling as an Immunometabolic Regulator in COVID-19: Mechanistic Insights and Therapeutic Potential
    Ali Alqarni, Hayder Mutter Al-Kuraishy, Mohammed A Alqarni, Duaa Eliwa, Ali Ismail Al-Gareeb, Mostafa M. Bahaa, Gaber El‐Saber Batiha · 2026 · Immunological Investigations
  32. Identification of endogenous retroviruses linked to IL-1-mediated immunopathology in severe COVID-19
    Maria Tokuyama, Bessie Wang, Thomas Deckers, Eric Liu · 2026 · Research Square